Related Experiment Video
Updated: Jun 10, 2026

10:35
Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
Dual Activity Microbial Peptides Catalog
Özlem Sağıroğlu1,2, Muzaffer Arıkan3
1Program of Biotechnology, Department of Biology, Institute of Graduate Studies in Sciences, Istanbul University, Istanbul, 34134, Türkiye.
Scientific Data
|June 8, 2026
Summary
Researchers identified dual-activity antimicrobial peptides (AMPs) and anticancer peptides (ACPs) from microbial sources. The Dual Activity Microbial Peptides Catalog (DAMPC) offers a new resource for these promising therapeutic agents.
Area of Science:
- Microbiology
- Biochemistry
- Computational Biology
Background:
- Antibiotic resistance and cancer are critical global health threats.
- Antimicrobial peptides (AMPs) show promise as alternatives to antibiotics.
- Some AMPs also possess anticancer peptide (ACP) activity, offering dual therapeutic potential.
Purpose of the Study:
- To identify microbial peptides with dual antimicrobial and anticancer activity.
- To address the underrepresentation of ACPs in databases by exploring microbial sources.
- To create a curated catalog of these dual-activity peptides.
Main Methods:
- Utilized a consensus strategy with three ACP and two AMP prediction tools.
- Screened over 124 million microbial small open reading frames (smORFs).
- Filtered for non-toxic peptides exhibiting dual activity.
Main Results:
- Identified 40,251 non-toxic microbial peptides with dual AMP and ACP properties.
- Compiled these findings into the Dual Activity Microbial Peptides Catalog (DAMPC).
- DAMPC is a searchable resource for dual-activity, non-toxic microbial peptide sequences.
Conclusions:
- Microbial sources harbor a significant number of peptides with dual antimicrobial and anticancer activities.
- The DAMPC provides a valuable resource for further research and development of novel therapeutics.
- This catalog facilitates the exploration of microbial peptides for combating antibiotic resistance and cancer.
